Speakers:
Toshiki Fukasawa, PhD: Real-World Evidence from Japan: Healthcare Infrastructure, Data Resources, and Emerging Pharmacoepidemiologic Insights
Toshiki Fukasawa is a Program-Specific Junior Associate Professor in the Department of Pharmacoepidemiology at Kyoto University. He also serves as an advisor to JMDC Inc., a leading provider of electronic healthcare databases in Japan. His research leverages these databases to evaluate drug utilization, safety, and effectiveness across multiple therapeutic areas. Recent work has applied target trial emulation and other causal inference methods to assess the safety and effectiveness of pharmacotherapies for renal, musculoskeletal, and diabetes-related conditions.
Takanori Yanai, MD, PhD: Current Practice of Pediatric Care in Japan and Introduction of My Epidemiological Studies
Takanori Yanai is a pediatric specialist and assistant professor at Kyoto University. He graduated from medical school in 2010 and worked as a pediatrician at a university hospital before joining Kyoto University in 2021, where he earned his PhD in 2024. His research focuses on pediatrics, maternal and child health, public health, and clinical research. He has conducted time-series analyses of inpatient disease trends before and after vaccine introduction and studied the link between infant exposures and disease incidence under the DOHaD hypothesis.
Takayuki Okura, MD, PhD: Challenges in Infectious Disease Epidemiology and Surveillance Programs in Japan
Takayuki Okura is an infectious disease specialist and visiting researcher at Kyoto University. He graduated from medical school in 2008 and began his residency in internal medicine at a national hospital. In 2021, he entered the Graduate School of Medicine at Kyoto University, where he conducted research and earned his PhD in 2025. His research focuses on public health aspects of infectious diseases and the effectiveness of antimicrobial agents. He has demonstrated that COVID-19 is a risk factor for gastrointestinal perforation through a self-controlled case series study.